サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1239511

PCAポンプ（自己調節鎮痛ポンプ）市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2021-2031年

Patient Controlled Analgesia Pumps Market By Type, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 235 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
PCAポンプ（自己調節鎮痛ポンプ）市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2021-2031年
出版日: 2023年01月01日
発行: Allied Market Research
ページ情報: 英文 235 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

PCAポンプ（自己調節鎮痛ポンプ）の市場規模は、2021年に2億7,767万米ドルと評価され、2022年から2031年にかけて3.9%のCAGRを示し、2031年には4億789万米ドルに達すると予測されています。

PCA（自己調節鎮痛）は、患者が痛みをコントロールできる効果的な疼痛管理技術です。これらのポンプは、ヒドロモルフォン、フェンタニル、モルヒネなどのオピオイド鎮痛剤を供給します。ポンプは、静脈に挿入される小さな柔軟なチューブである静脈ライン（IV）に接続されています。通常、この薬はボタンが押されたときに投与されます。これらのポンプは、制御された量で患者さんの体内に薬を送り込む医療機器です。鎮痛ポンプは、病院、介護施設、在宅などの臨床現場で使用されることが多くなっています。モルヒネ、フェンタニル、ヒドロモルフォンなどの薬剤を投与するために使用されます。PCAポンプは、安全な使用、患者の満足度、鎮静作用の軽減、投薬量の削減、ポンプが空になったときのアラートによる看護チームへの通知などの利点があります。

PCAにはコンピューター制御のポンプが搭載されており、手術後の回復期にある患者さんによく使用されます。術後管理に採用されています。患者さんに痛みをコントロールする力を提供する方法です。また、PCAは、口から薬を摂取することが困難な患者さんにとって有益です。場合によっては、投与量を設定し、ボタンを押すだけで患者さん自身が追加投与することも可能です。PCA薬は、経口、静脈、硬膜外、吸入、鼻腔スプレー、経皮など、さまざまな経路で投与することが可能です。

PCAポンプは、急性痛、慢性痛、術後痛、陣痛などの治療に使用され、特に経口薬の投与が困難な人の治療に使用されます。急病院でのオピオイド初期投与では痛みを和らげるのに不十分な急性疼痛の場合、PCAポンプは有用です。一般的な例としては、火傷、外傷、膵炎、血管閉塞性疼痛クライシスなどが挙げられます。

PCAポンプの世界市場の成長は、がん性疼痛、整形外科疾患、鎌状赤血球症などの痛みを和らげるための鎮痛ポンプの需要の増加、鎮痛ポンプを必要とする外科手術の数の増加などが主な要因です。しかし、新興国では高度なPCAポンプに関する知識が不足しており、製品承認のための規制が市場の成長を妨げています。逆に、PCAポンプの需要の増加や鎮痛ポンプの技術的進歩は、市場関係者に有利な機会を提供すると予想されます。疾病負担の増加により、投薬ミスの可能性が存在します。そのため、より安全で効率的、かつ標準化された高度な送達システムが必要とされています。また、先進的なPCAポンプの導入は、市場に有利な成長機会を提供します。

老年人口の増加、慢性疼痛の有病率の上昇、低コストなどの要因が、市場を推進する可能性が高いです。さらに、がんやその他の疾患で手術を受ける人の数が世界的に増加していることも、市場の成長に好影響を与える可能性があります。がん、鎌状赤血球症、整形外科などの疾病の発生率の増加が、PCAポンプの需要の増加に繋がっています。例えば、疾病管理予防センター（CDC）によると、2022年5月に鎌状赤血球病に罹患するアメリカ人が約10万人いると推定されています。このように、鎌状赤血球病の有病率の上昇は、PCAポンプへの取り込みを増加させ、市場成長を牽引しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な影響要因
    • 主な投資ポケット
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 適度な競争の激しさ
  • 市場力学
    • 促進要因
      • 慢性疼痛疾患の増加
      • 鎮痛ポンプの技術的進歩
      • 手術件数の増加
    • 抑制要因
      • 鎮痛ポンプに関する認識の欠如
      • 厳しい政府規制
    • 機会
      • 新興諸国における有利な成長機会
      • 鎮痛ポンプの開発
  • 市場におけるCOVID-19影響分析

第4章 PCAポンプ（自己調節鎮痛ポンプ）市場：タイプ別

  • 概要
    • 市場規模と予測
  • 電子およびワイヤレス
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 機械式
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第5章 PCAポンプ（自己調節鎮痛ポンプ）市場：用途別

  • 概要
    • 市場規模と予測
  • 腫瘍および血液
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 消化器
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • その他
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第6章 PCAポンプ（自己調節鎮痛ポンプ）市場：エンドユーザー別

  • 概要
    • 市場規模と予測
  • 病院
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 外来手術センター
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • その他
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第7章 PCAポンプ（自己調節鎮痛ポンプ）市場：地域別

  • 概要
    • 市場規模と予測：地域別
  • 北米
    • 主な動向と機会
    • 市場規模と予測：タイプ別
    • 市場規模と予測：用途別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • 米国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • カナダ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • メキシコ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
  • 欧州
    • 主な動向と機会
    • 市場規模と予測：タイプ別
    • 市場規模と予測：用途別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • ドイツ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • フランス
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • 英国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • イタリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • スペイン
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • その他欧州
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
  • アジア太平洋
    • 主な動向と機会
    • 市場規模と予測：タイプ別
    • 市場規模と予測：用途別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • 日本
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • 中国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • インド
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • オーストラリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • 韓国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • その他アジア太平洋地域
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
  • ラテンアメリカ・中東・アフリカ
    • 主な動向と機会
    • 市場規模と予測：タイプ別
    • 市場規模と予測：用途別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • ブラジル
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • サウジアラビア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • 南アフリカ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • その他のラテンアメリカ・中東・アフリカ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：タイプ別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • トップ 10プレーヤーの製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • トッププレーヤーのポジショニング、2021

第9章 企業プロファイル

  • Ace-medical
  • Arcomed AG
  • B. Braun SE
  • Becton, Dickinson and Company
  • Henan Tuoren Medical Device Co., Ltd.
  • ICU Medical, Inc.
  • Micrel Medical Devices SA
  • Fresenius SE and Co. KGaA
  • Changzhou Medical Bioengineering Co., Ltd.
  • SCW Medicath Ltd
図表

LIST OF TABLES

  • TABLE 01. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ELECTRONIC AND WIRELESS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR MECHANICAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ONCOLOGY AND HEMATOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR GASTROENTEROLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. ACE-MEDICAL: KEY EXECUTIVES
  • TABLE 87. ACE-MEDICAL: COMPANY SNAPSHOT
  • TABLE 88. ACE-MEDICAL: PRODUCT SEGMENTS
  • TABLE 89. ACE-MEDICAL: PRODUCT PORTFOLIO
  • TABLE 90. ARCOMED AG: KEY EXECUTIVES
  • TABLE 91. ARCOMED AG: COMPANY SNAPSHOT
  • TABLE 92. ARCOMED AG: PRODUCT SEGMENTS
  • TABLE 93. ARCOMED AG: PRODUCT PORTFOLIO
  • TABLE 94. B. BRAUN SE: KEY EXECUTIVES
  • TABLE 95. B. BRAUN SE: COMPANY SNAPSHOT
  • TABLE 96. B. BRAUN SE: PRODUCT SEGMENTS
  • TABLE 97. B. BRAUN SE: PRODUCT PORTFOLIO
  • TABLE 98. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 99. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 100. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
  • TABLE 101. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 102. HENAN TUOREN MEDICAL DEVICE CO., LTD.: KEY EXECUTIVES
  • TABLE 103. HENAN TUOREN MEDICAL DEVICE CO., LTD.: COMPANY SNAPSHOT
  • TABLE 104. HENAN TUOREN MEDICAL DEVICE CO., LTD.: PRODUCT SEGMENTS
  • TABLE 105. HENAN TUOREN MEDICAL DEVICE CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 106. ICU MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 107. ICU MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 108. ICU MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 109. ICU MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 110. ICU MEDICAL, INC.: KEY STRATERGIES
  • TABLE 111. MICREL MEDICAL DEVICES SA: KEY EXECUTIVES
  • TABLE 112. MICREL MEDICAL DEVICES SA: COMPANY SNAPSHOT
  • TABLE 113. MICREL MEDICAL DEVICES SA: PRODUCT SEGMENTS
  • TABLE 114. MICREL MEDICAL DEVICES SA: PRODUCT PORTFOLIO
  • TABLE 115. FRESENIUS SE AND CO. KGAA: KEY EXECUTIVES
  • TABLE 116. FRESENIUS SE AND CO. KGAA: COMPANY SNAPSHOT
  • TABLE 117. FRESENIUS SE AND CO. KGAA: PRODUCT SEGMENTS
  • TABLE 118. FRESENIUS SE AND CO. KGAA: PRODUCT PORTFOLIO
  • TABLE 119. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: KEY EXECUTIVES
  • TABLE 120. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: COMPANY SNAPSHOT
  • TABLE 121. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: PRODUCT SEGMENTS
  • TABLE 122. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 123. SCW MEDICATH LTD: KEY EXECUTIVES
  • TABLE 124. SCW MEDICATH LTD: COMPANY SNAPSHOT
  • TABLE 125. SCW MEDICATH LTD: PRODUCT SEGMENTS
  • TABLE 126. SCW MEDICATH LTD: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN PATIENT CONTROLLED ANALGESIA PUMPS MARKET (2022-2031)
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALPATIENT CONTROLLED ANALGESIA PUMPS MARKET
  • FIGURE 10. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ELECTRONIC AND WIRELESS, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR MECHANICAL, BY COUNTRY 2021-2031(%)
  • FIGURE 13. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ONCOLOGY AND HEMATOLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR GASTROENTEROLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 17. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 21. PATIENT CONTROLLED ANALGESIA PUMPS MARKET BY REGION, 2021
  • FIGURE 22. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45. COMPETITIVE DASHBOARD
  • FIGURE 46. COMPETITIVE HEATMAP: PATIENT CONTROLLED ANALGESIA PUMPS MARKET
  • FIGURE 47. TOP PLAYER POSITIONING, 2021
  • FIGURE 48. B. BRAUN SE: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 49. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 50. B. BRAUN SE: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 51. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 52. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 53. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 54. ICU MEDICAL, INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 55. ICU MEDICAL, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 56. ICU MEDICAL, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 57. FRESENIUS SE AND CO. KGAA: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 58. FRESENIUS SE AND CO. KGAA: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. FRESENIUS SE AND CO. KGAA: REVENUE SHARE BY REGION, 2021 (%)
目次
Product Code: A13386

The patient controlled analgesia pumps market size valued for $277.67 million in 2021 and is estimated to reach $407.89 million by 2031, exhibiting a CAGR of 3.9% from 2022 to 2031.  

Patient-controlled analgesia (PCA) is an effective pain management technique that offers the patient control over their pain. These pumps deliver opioid painkillers such hydromorphone, fentanyl, and morphine. The pump is attached to an intravenous (IV) line, which is a small, flexible tube inserted into a vein. Normally, this medication is administered when the button is pressed. These pumps are medical devices that deliver the medications into a patient's body in controlled amounts. Analgesic pumps are increasingly used in clinical settings such as hospitals, nursing homes, and in home. The applications of these analgesic pumps for delivery of medications such as morphine, fentanyl and hydromorphone. The PCA pump have the advantages such as safe to use, patient satisfaction, less sedation, reduced medication, and the nursing team is informed by an alert when the pump is empty.

PCA is equipped with a computerized pump, which is often used by patients recovering from surgery. It is employed for post-operative management. It is a method of pain control that provides patients with the power to control their pain. In addition, PCA is beneficial for patients who find difficulty in consuming medication by mouth. In some cases, the dose is set and an additional dose can be administered by patients themselves just by pressing a button. The patient-controlled analgesia can be administered by various routes, including oral, intravenous, epidural, inhaled, nasal spray, and transcutaneous.  

Patient controlled analgesia pumps are used to treat acute, chronic, postoperative, and labor pain, particularly in individuals who are unable to receive oral medications. In cases of acute pain in which the initial opioid dose in urgent care was insufficient to relieve pain thus, patient-controlled analgesia pumps can be useful. Some examples of common cases include burns, trauma, pancreatitis, and vaso-occlusive pain crises. 

The growth of global patient controlled analgesia pumps market is majorly driven by increase in demand for analgesic pumps to relieve the pain such as cancer pain, orthopedic, and sickle cell crises pain, rise in number of surgical procedures which requires the analgesic pumps. However, lack of knowledge regarding advanced patient controlled analgesic pumps in emerging countries and regulations for product approval hinders the market growth. Conversely, increase in demand for patient controlled analgesic pumps and rise in technological advancements in analgesic pumps are anticipated to provide lucrative opportunities to the market players. The possibility of medication errors exists due to increase in disease burden. Thus, there is a need for advanced delivery systems that are safer, more efficient, and standardized. In addition, the introduction of advanced PCA pumps provides the lucrative growth opportunities for the market. 

Factors such as surge in geriatric population, rise in prevalence of chronic pain, and low cost are likely to propel the market. Moreover, rise in the number of individuals undergoing surgeries globally for cancer, or other ailments is likely to have a positive impact on the market growth. Rise in incidence of diseases such as cancer, sickle cell disease, and orthopedics has led to an increase in demand for patient controlled analgesic pump devices. For instance, according to the Centers for Disease Control and Prevention (CDC), estimated that approximately 100,000 Americans affected with sickle cell disease in May 2022. Thus, rise in prevalence of sickle cell disease has increased the uptake for PCA pumps and thus drives the market growth.  

The global patient controlled analgesia pumps market is segmented into type, application, end user, and region. By type, the market is categorized into electronic & wireless and mechanical. On the basis of application, the market is segregated into oncology & hematology, gastroenterology, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major Key players that operate in the global patient controlled analgesia pumps market are: Ace-medical, Arcomed AG, B. Braun SE, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE and Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, SCW Medicath Ltd. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient controlled analgesia pumps market analysis from 2021 to 2031 to identify the prevailing patient controlled analgesia pumps market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the patient controlled analgesia pumps market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global patient controlled analgesia pumps market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Electronic and Wireless
  • Mechanical

By Application

  • Oncology and hematology
  • Gastroenterology
  • Others

By End user

  • Hospitals
  • Ambulatory surgical centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Ace-medical
  • B. Braun SE
  • ICU Medical, Inc.
  • SCW Medicath Ltd
  • Changzhou Medical Bioengineering Co., Ltd.
  • Arcomed AG
  • Becton, Dickinson and Company
  • Henan Tuoren Medical Device Co., Ltd.
  • Fresenius SE and Co. KGaA
  • Micrel Medical Devices SA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate threat of new entrants
    • 3.3.5. Moderate intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in cases of chronic pain diseases
      • 3.4.1.2. Technological advancements in analgesic pumps
      • 3.4.1.3. Increase in number of surgeries
    • 3.4.2. Restraints
      • 3.4.2.1. Lack of awareness regarding analgesia pumps
      • 3.4.2.2. Stringent government regulations
    • 3.4.3. Opportunities
      • 3.4.3.1. Lucrative growth opportunities in developing countries
      • 3.4.3.2. Development in analgesic pumps
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Electronic and Wireless
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Mechanical
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Oncology and hematology
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Gastroenterology
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Ambulatory surgical centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End user
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by End user
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by End user
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by End user
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End user
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by End user
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by End user
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by End user
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by End user
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by End user
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by End user
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End user
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by End user
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by End user
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by End user
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by End user
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by End user
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Type
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by End user
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End user
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by End user
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by End user
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by End user
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by End user

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Ace-medical
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
  • 9.2. Arcomed AG
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
  • 9.3. B. Braun SE
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Becton, Dickinson and Company
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Henan Tuoren Medical Device Co., Ltd.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. ICU Medical, Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Micrel Medical Devices SA
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Fresenius SE and Co. KGaA
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. Changzhou Medical Bioengineering Co., Ltd.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. SCW Medicath Ltd
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio